White matter hyperintensity volume correlates with matrix metalloproteinase-2 in acute ischemic stroke.

BACKGROUND White matter hyperintensity (WMH), a common radiographic finding associated with stroke risk and outcome, has been linked to matrix metalloproteinase (MMP) activity and increased levels of oxidative stress in nonstroke populations. We sought to determine whether WMH severity is associated with plasma levels of MMPs and oxidative stress (F2-isoprostane) in subjects with acute ischemic stroke (AIS). METHODS We measured plasma biomarker levels at baseline and 48 hours in consecutive AIS subjects. White matter hyperintensity volume (WMHv) was quantified on admission magnetic resonance imaging using a validated semiautomated protocol, and Spearman correlation coefficients were derived for all measured biomarkers. RESULTS We enrolled 405 AIS subjects (mean age 70±15 years; 58% male; median WMHv 3.4 cm3, interquartile range 1.4-9.5). WMHv and age were strongly correlated (ρ=.57, P<.0001). WMHv and MMP-2 levels were correlated at baseline (ρ=.23, P<.0001) and at 48 hours poststroke (ρ=.19, P=.002). In multivariate analysis, 48-hour MMP-2 levels were independently associated with WMHv (β=.12, P=.04). MMP-9 and F2-isioprostane levels did not correlate with WMHv. CONCLUSIONS In AIS patients, MMP-2 levels are associated with the pre-existing burden of WMH. If validated, these findings may further elucidate the role of MMP-2 in pathophysiology of chronic cerebrovascular injury, such as WMH, and in brain susceptibility to acute ischemia.

[1]  P. Sandercock,et al.  Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia? , 2003, Stroke.

[2]  F. Fazekas,et al.  Magnetic resonance imaging white matter hyperintensities in clinically normal elderly individuals. Correlations with plasma concentrations of naturally occurring antioxidants. , 1996, Stroke.

[3]  Shotai Kobayashi,et al.  Correlation of NO Metabolites and 8-Iso-Prostaglandin F2a With Periventricular Hyperintensity Severity , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[4]  Jeffrey L. Saver,et al.  Cerebral White Matter Hyperintensities on MRI: Current Concepts and Therapeutic Implications , 2006, Cerebrovascular Diseases.

[5]  G. Rosenberg,et al.  Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. , 2011, Stroke.

[6]  Leukoaraiosis and dementia: To the editor , 1990 .

[7]  E. Air,et al.  Clinical Prediction of Functional Outcome After Ischemic Stroke: The Surprising Importance of Periventricular White Matter Disease and Race , 2009, Stroke.

[8]  F. Howe,et al.  Blood–brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[9]  J. Morrow Quantification of Isoprostanes as Indices of Oxidant Stress and the Risk of Atherosclerosis in Humans , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[10]  Eric E. Smith,et al.  White matter hyperintensity volume is increased in small vessel stroke subtypes , 2010, Neurology.

[11]  E. Candelario-Jalil,et al.  Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics. , 2009, Current opinion in investigational drugs.

[12]  W. Ding,et al.  Electron Paramagnetic Resonance-Guided Normobaric Hyperoxia Treatment Protects the Brain by Maintaining Penumbral Oxygenation in a Rat Model of Transient Focal Cerebral Ischemia , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  Eric E. Smith,et al.  Severity of leukoaraiosis correlates with clinical outcome after ischemic stroke , 2009, Neurology.

[14]  Paul A Armitage,et al.  Changes in Background Blood–Brain Barrier Integrity Between Lacunar and Cortical Ischemic Stroke Subtypes , 2008, Stroke.

[15]  RyosukeTakahashi,et al.  Matrix Metalloproteinase-2 Plays a Critical Role in the Pathogenesis of White Matter Lesions After Chronic Cerebral Hypoperfusion in Rodents , 2006 .

[16]  D. Mezzapesa,et al.  Different roles of matrix metalloproteinases-2 and -9 after human ischaemic stroke , 2007, Neurological Sciences.

[17]  Jeffrey F. Thompson,et al.  Matrix Metalloproteinases Are Associated With Increased Blood–Brain Barrier Opening in Vascular Cognitive Impairment , 2011, Stroke.

[18]  A Gregory Sorensen,et al.  Severity of Leukoaraiosis and Susceptibility to Infarct Growth in Acute Stroke , 2008, Stroke.

[19]  K. Sung,et al.  Minocycline attenuates white matter damage in a rat model of chronic cerebral hypoperfusion , 2006, Journal of neuroscience research.

[20]  H. Shibasaki,et al.  Chronic Cerebral Hypoperfusion Induces MMP-2 but Not MMP-9 Expression in the Microglia and Vascular Endothelium of White Matter , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  J. Garcìa,et al.  Pathogenesis of leukoaraiosis: a review. , 1997, Stroke.

[22]  J. Helenius,et al.  Treatment of leukoaraiosis: a futuristic view. , 2007, Current drug targets.